Anchordx
Guangzhou, CN · 2 known investors
AnchorDx develops, manufactures, and sells cancer early-screening and diagnostic products based on ctDNA methylation high-throughput sequencing, along with related testing services covering over 70% of high-incidence cancers such as lung, breast, digestive, and urinary cancers. Founded in 2015 in Guangzhou, China with R&D centers in China and the US, it also runs a big-data and AI platform focused on lung cancer detection and treatment.
Founders & leadership
范
范建兵Founder
Investors · 2
Frequently asked questions
- What does Anchordx do?
- AnchorDx develops, manufactures, and sells cancer early-screening and diagnostic products based on ctDNA methylation high-throughput sequencing, along with related testing services covering over 70% of high-incidence cancers such as lung, breast, digestive, and urinary cancers. Founded in 2015 in Guangzhou, China with R&D centers in China and the US, it also runs a big-data and AI platform focused on lung cancer detection and treatment.
- Who founded Anchordx?
- Anchordx was founded by 范建兵.
- Who are Anchordx's investors?
- Anchordx's investors include Marathon Venture Partners, OrbiMed.
- Where is Anchordx headquartered?
- Anchordx is headquartered in Guangzhou, CN.